GLPBio

Latrunculin B

Catalog No.: GC17006Purity:>96.00%
Latrunculin B is a cell-permeable actin polymerization inhibitor in vitro and in vivo by the formation of a 1:1 complex with monomeric G-actin and thereby inhibit actin polymerization.Latrunculin B regulates pulmonary vein electrophysiological characteristics and attenuates stretch-induced arrhythmogenesis.

Products are for research use only. Not for human use. We do not sell to patients.


Latrunculin B
Cas No.: 76343-94-7
500ugIn Stock
$230.00
1
1mgIn Stock
$299.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

Latrunculin B is a cell-permeable actin polymerization inhibitor in vitro and in vivo by the formation of a 1:1 complex with monomeric G-actin and thereby inhibit actin polymerization.Latrunculin B regulates pulmonary vein electrophysiological characteristics and attenuates stretch-induced arrhythmogenesis [1].

Latrunculin B (0-10μM; 60min) treatment of CH27 cells depolymerized actin filaments. Treatment of cells with Latrunculin B (0.1μM; 30min) reduced ghost pen cyclic peptide staining and resulted in changes in the cellular distribution of BCR [2].Latrunculin B (100nM; 30min) decreases the late Na+ current, L-type Ca2+ current, Na+/Ca2+ exchanger current, and stretch-activated BKCa current in PV cardiomyocytes [3]. Latrunculin B displays growth inhibition of HeLa cells with an IC50 value of 1.4μM [4].

Latrunculin B (0.5μM/day; ip; 2months) restored the frequency and number of FO B cells in Rictor KO mice compared with Rictor KO mice treated with vector only, but had no effect on MZ B cell formation, and also restored the levels of pY or pBtk in Rictor KO mice [5]. Treatment of eggs with latrunculin B (5, 10 and 20μg/ml; 90min) resulted in a decrease in the incidence of fertilization [6].

References:
[1] Youssef D T A, Asfour H Z, Genta-Jouve G, et al. Magnificines A and B, antimicrobial marine alkaloids featuring a tetrahydrooxazolo [3, 2-a] azepine-2, 5 (3H, 6H)-dione backbone from the Red Sea sponge Negombata magnifica[J]. Marine Drugs, 2021, 19(4): 214.
[2] Brown BK, Song W. The actin cytoskeleton is required for the trafficking of the B cell antigen receptor to the late endosomes. Traffic. 2001 Jun;2(6):414-27.
[3]Lu Y Y, Lin Y K, Wen Z H, et al. Latrunculin B modulates electrophysiological characteristics and arrhythmogenesis in pulmonary vein cardiomyocytes[J]. Clinical Science, 2016, 130(9): 721-732.
[4] oussef DTA, Asfour HZ, Genta-Jouve G, Shaala LA. Magnificines A and B, Antimicrobial Marine Alkaloids Featuring a Tetrahydrooxazolo[3,2-a]azepine-2,5(3H,6H)-dione Backbone from the Red Sea Sponge Negombata magnifica. Mar Drugs. 2021 Apr 12;19(4):214.
[5] Huang L, Zhang Y, Xu C, Gu X, Niu L, Wang J, Sun X, Bai X, Xuan X, Li Q, Shi C, Yu B, Miller H, Yang G, Westerberg LS, Liu W, Song W, Zhao X, Liu C. Rictor positively regulates B cell receptor signaling by modulating actin reorganization via ezrin. PLoS Biol. 2017 Aug 18;15(8):e2001750.
[6] McAvey BA, Wortzman GB, Williams CJ, Evans JP. Involvement of calcium signaling and the actin cytoskeleton in the membrane block to polyspermy in mouse eggs. Biol Reprod. 2002 Oct;67(4):1342-52.

Protocol

Cell experiment [1]:

Cell lines

B cells

Preparation Method

B cells were treated with Latrunculin B (10μM) for 30 minutes at 37°C.

Reaction Conditions

Latrunculin B: 10μM; 30min

Applications

In co-localization, it was found that BCR and pMst1 co-localization was reduced after treatment with Latrunculin B.

Animal experiment [2]:

Animal models

Murine syngeneic renal cell carcinoma cells model

Preparation Method

Rictor KO mice were fed with Latrunculin B (0.5μM/day; ip) every week for 2 months.

Dosage form

Latrunculin B: 0.5μM/day; ip; 2months

Applications

Latrunculin B(0.5μM; ip) restored the frequency and number of FO B cells in Rictor KO mice compared with Rictor KO mice treated with vector only, but had no effect on MZ B cell formation, and also restored the levels of pY or pBtk in Rictor KO mice.

References:
[1] Huang L, Sun X, Yang D, Dai X, Jiang P, Bai X, Zhang Y, Wang J, Li W, Miller H, Song W, Treanor B, Zhao X, Liu C. WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. Blood Adv. 2020 Feb 11;4(3):573-585.
[2] Huang L, Zhang Y, Xu C, Gu X, Niu L, Wang J, Sun X, Bai X, Xuan X, Li Q, Shi C, Yu B, Miller H, Yang G, Westerberg LS, Liu W, Song W, Zhao X, Liu C. Rictor positively regulates B cell receptor signaling by modulating actin reorganization via ezrin. PLoS Biol. 2017 Aug 18;15(8):e2001750.

Product Documents

Purity:>96.00%Appearance:A film

Chemical Properties

CAS No.
76343-94-7
Chemical Name
4R-[(1R,4Z,8Z,10S,13R,15R)-15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-2-thiazolidinone
SMILES
C/C(CC/C=C\[C@@H](C)CC[C@@H]1C[C@@H]2C[C@@]([C@H]3N([H])C(SC3)=O)(O)O1)=C/C(O2)=O
Molecular Formula
C20H29NO5S
Molecular Weight
395.5
Solubility
≤25mg/ml in DMSO; 25 mg/ml in Ethanol
Storage
Store at -20°C,protect from light
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for Latrunculin B

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%